ALT5 Sigma Corp. (ALTS)
NASDAQ: ALTS · IEX Real-Time Price · USD
38.49
+36.23 (1,603.26%)
May 2, 2022, 4:00 PM EDT - Market closed
Company Description
JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction.
Its lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain.
The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019.
JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.
ALT5 Sigma Corp.
| Country | United States |
| Founded | 1976 |
| Industry | Waste Management |
| Sector | Industrials |
| Employees | 5 |
| CEO | Tony Isaac |
Contact Details
Address: 325 E. Warm Springs Road, Suite 102 Las Vegas, Nevada 89119 United States | |
| Phone | 702-997-5968 |
Stock Details
| Ticker Symbol | ALTS |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000862861 |
| CUSIP Number | 74347B813 |
| ISIN Number | US74347B8138 |
| Employer ID | 41-1454591 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Tony Isaac | President, Chief Executive Officer, Corporate Secretary, Treasurer and Director |
| Virland A. Johnson CPA | Chief Financial Officer |
| Dr. Tony Giordano Ph.D. | Chief Scientific Officer |
| Dr. Douglas Flanagan | Chief Formulation Advisor |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 17, 2024 | 8-K | Current Report |
| Jun 21, 2024 | 8-K | Current Report |
| Jun 21, 2024 | 424B5 | Filing |
| Jun 5, 2024 | 8-K/A | [Amend] Current report |
| Jun 4, 2024 | 8-K | Current Report |
| May 31, 2024 | 8-K | Current Report |
| May 23, 2024 | 424B5 | Filing |
| May 21, 2024 | 8-K | Current Report |
| May 6, 2024 | 8-K | Current Report |
| May 6, 2024 | 424B5 | Filing |